Clicks Group Limited (JSE:CLS)
South Africa
· Delayed Price · Currency is ZAR · Price in ZAc | Market Cap | 61.66B |
| Revenue (ttm) | 49.54B |
| Net Income (ttm) | 3.33B |
| Shares Out | 233.85M |
| EPS (ttm) | 14.14 |
| PE Ratio | 18.65 |
| Forward PE | 16.96 |
| Dividend | 8.86 (3.33%) |
| Ex-Dividend Date | Jul 1, 2026 |
| Volume | 1,145,079 |
| Average Volume | 934,264 |
| Open | 26,500 |
| Previous Close | 26,595 |
| Day's Range | 26,271 - 26,977 |
| 52-Week Range | 26,271 - 40,298 |
| Beta | 0.29 |
| RSI | 29.42 |
| Earnings Date | Apr 23, 2026 |
About Clicks Group
Clicks Group Limited, together with its subsidiaries, operates as a health, wellness, and beauty retailer in South Africa and internationally. The company operates through two segments, Retail and Distribution. It provides retail, including Clicks, a specialist health, beauty and homeware retailer; Sorbet, a franchise of hair and beauty salons; 180 Degrees Marketing, a software development company; and The Body shop, which specializes in naturally inspired luxury toiletries, cosmetics, gifting and grooming, with stores. The company also offers ... [Read more]
Financial Performance
In fiscal year 2025, Clicks Group's revenue was 47.83 billion, an increase of 5.26% compared to the previous year's 45.44 billion. Earnings were 3.24 billion, an increase of 14.07%.
Financial StatementsNews
Clicks Group Earnings Call Transcript: H1 2026
Turnover grew 7.4% and diluted HEPS rose 8.1% year-over-year, with strong cash generation and expanded retail and pharmacy footprint. Guidance for full-year HEPS growth is 4%-9% amid economic uncertainty and competitive pressures.
Clicks Group Earnings Call Transcript: H2 2025
Diluted headline EPS grew 14.1% and return on equity reached 49.2%, with strong cash generation and market share gains in health, beauty, and baby categories. Store and pharmacy expansion continues, supported by disciplined capital allocation and investments in systems and sustainability.
Clicks Group Transcript: Deutsche Bank ADR Virtual Investor Conference
The group is executing a strategic roadmap focused on store modernization, omnichannel growth, and efficiency through technology investments. Expansion targets include reaching 1,200 stores and a pharmacy in every location, with strong loyalty and private label performance supporting margins.
Clicks Group Earnings Call Transcript: H1 2025
Diluted HEPS rose 13.2% and group turnover grew 6.2% year-over-year, with strong retail and UPD performance. The group plans 45-55 new stores and pharmacies, maintains robust capital returns, and forecasts 11%-16% HEPS growth for the year.
Clicks Group Earnings Call Transcript: H2 2024
Annual results showed strong growth in EPS, turnover, and margins, with robust retail and UPD performance. Pharmacy expansion resumes post-Unicorn resolution, and medium-term margin guidance is raised amid improving consumer conditions.